Descrizione

Exosome-based therapies for alopecia, showing how extracellular vesicles derived from stem cells may deliver growth factors and signaling molecules to hair follicles.

Figure 6

Diagram

Source Paper

Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.

Pharmaceutics (2022)

PMID: 35335987

DOI: 10.3390/pharmaceutics14030612

Cite This Figure

![Figure 6: Exosome-based therapies for alopecia, showing how extracellular vesicles derived from stem cells may deliver growth factors and signaling molecules to hair follicles.]()

> Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." *Pharmaceutics*, 2022. PMID: [35335987](https://pubmed.ncbi.nlm.nih.gov/35335987/)

<figure>
  <img src="" alt="Exosome-based therapies for alopecia, showing how extracellular vesicles derived from stem cells may deliver growth factors and signaling molecules to hair follicles." />
  <figcaption>Figure 6. Exosome-based therapies for alopecia, showing how extracellular vesicles derived from stem cells may deliver growth factors and signaling molecules to hair follicles.<br>  Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." <em>Pharmaceutics</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35335987/">35335987</a></figcaption>
</figure>

Evidenze correlate

Minoxidil per Alopecia androgenetica

Grado A · 299 studi

Finasteride per Alopecia androgenetica

Grado A · 206 studi

Terapia PRP per Alopecia areata

Grado A · 89 studi

Minoxidil per Alopecia areata

Grado A · 122 studi

Terapia PRP per Alopecia androgenetica

Grado A · 144 studi